ストックスクリーナーアプリを入手
55.83
0.07%
0.04
アフターアワーズ：
56.00
0.17
+0.30%
Bristol Myers Squibb Co (BMY) 最新ニュース
Insider trades: JPMorgan, Bristol-Myers Squibb among notable names this week - MSN
Insider trades: JPMorgan, Bristol-Myers Squibb among notable names this week (BMY:NYSE) - Seeking Alpha
Bristol Myers Squibb CEO Christopher Boerner buys $110,096 in stock - Investing.com India
Bristol Myers Squibb CEO Christopher Boerner buys $110,096 in stock By Investing.com - Investing.com UK
Bristol Myers Squibb CEO Acquires 2,000 Shares - TradingView
Bristol-Myers GC Sandra Leung To Retire After 33 Years - Law360
BMY: 3 Precision Medicine Stocks That Could Transform Healthcare - StockNews.com
CAPLYTA’s Strong Market Adoption Propels Its Rise as a Leading Antipsychotic Therapy | DelveInsight - GlobeNewswire Inc.
Cell Therapy Market Is Booming So Rapidly with Forecast by 2032 | Bristol Myers Squibb Company, Amgen, Johnson - EIN News
Paradigm Asset Management Co. LLC Has $2.23 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace
Clinical Trial Manager Job – at Bristol Myers Squibb, Apply Now! - BioTecNika
Braun Stacey Associates Inc. Makes New $19.71 Million Investment in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
High Potency Drug Market Top PlayersNovartis AG, Bristol-Myers Squibb Co, Sanofi, Takeda Pharmaceutical Co Ltd. - openPR
Truist Financial Corp Purchases 60,365 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol-Myers Squibb veteran general counsel to retire - | Governance Intelligence
GAM Holding AG Sells 39,363 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol Myers Squibb Names New GC as Legal Chief Retires - Bloomberg Law
Compugen Updates Filing Structure with Bristol Myers Squibb - MSN
BioArctic-Bristol Myers Squibb Alzheimer's Deal Clears US Regulatory Hurdle -February 20, 2025 at 01:43 am EST - Marketscreener.com
Bristol Myers Squibb exec Samit Hirawat acquires $99,999 in stock By Investing.com - Investing.com Nigeria
FTC approves Bioarctic's license agreement with Bristol Myers Squibb -February 20, 2025 at 01:18 am EST - Marketscreener.com
BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing - Yahoo Finance
BMYBristol-Myers Squibb Co Latest Stock News & Market Updates - StockTitan
Bristol Myers Squibb exec Samit Hirawat acquires $99,999 in stock - Investing.com India
Bristol Myers Squibb EVP Purchases Company Shares - TradingView
Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer - Benzinga
Bristol Myers Squibb GC to Retire After 33 years With Drugmaker - Law.com
Bristol Myers Squibb notches overall survival win with Opdivo in preoperative NSCLC - FiercePharma
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer - Business Wire
Convergence Investment Partners LLC Buys 6,888 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Rancho BioSciences Announces Bristol Myers Squibb Renews Membership for Phase 2 of the Single-Cell Data Science Consortium - BioSpace
Bristol Myers: positive Phase 3 data in NSCLC -February 19, 2025 at 07:48 am EST - Marketscreener.com
Bristol Myers announces new five-year results from POETYK PSO trial - Yahoo Finance
Valley Wealth Managers Inc. Sells 7,824 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
D.A. Davidson & CO. Purchases 7,343 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Allworth Financial LP Raises Holdings in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Rep. Julie Johnson Purchases Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Areas of interest - Bristol Myers Squibb
Cancer Therapy Market Is Booming Worldwide 2025-2032 | Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc. - openPR
Bank Pictet & Cie Europe AG Purchases Shares of 231,500 Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Position Increased by Roman Butler Fullerton & Co. - MarketBeat
Covenant Asset Management LLC Acquires New Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
New York State Teachers Retirement System Has $104.57 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
AustralianSuper Pty Ltd Sells 398,552 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol Myers Squibb: Opdivo-Qvantig is the first FDA approved subcutaneous version of cancer immunotherapy targeting PD-1 - 2 Minute Medicine
KLCM Advisors Inc. Decreases Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
AlphaCentric Advisors LLC Makes New $1.11 Million Investment in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now - Insider Monkey
Bristol Myers: positive five-year results for Sotyktu -February 17, 2025 at 02:04 am EST - Marketscreener.com
Bristol Myers Says New Schizophrenia Drug Off to Strong Start - MSN
Northern Financial Advisors Inc Invests $475,000 in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
10 Best Drug Stocks to Buy Now - Insider Monkey
Sheaff Brock Investment Advisors LLC Cuts Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Louisiana State Employees Retirement System Has $6.17 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
0.61%
0.07%
大文字化:
|
ボリューム (24 時間):